Skip to main content

Dr. Shakhnovich is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shakhnovich's full profile

Already have an account?

Education & Training

  • Children's Mercy Kansas City
    Children's Mercy Kansas City2011 - 2015
  • Children’s Mercy Hospital
    Children’s Mercy HospitalFellowship, Pediatric Gastroenterology, 2011 - 2014
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Pediatrics, 2008 - 2011
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 2008

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2011 - 2025
  • KS State Medical License
    KS State Medical License 2015 - 2023
  • WI State Medical License
    WI State Medical License 2009 - 2011
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Gastroenterology

Awards, Honors, & Recognition

  • Presidential Trainee Award American Society for Clinical Pharmacology and Therapeutics (ASCPT), 2014, 2016
  • Loan Repayment Program Award NIH
  • Young Faculty Clinical Research Investigator North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), 2015

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Rare Presentation of pancreatitis secondary to intussusceptions of duodenal duplication cyst: a pediatric case report.  
    V. Shakhnovich; J. Colombo; A. Desai; S. St. Peter, Journal of Pediatric Surgery Case Reports, 12/1/2014

Books/Book Chapters

Lectures

  • 49th Annual Arden Conference-American Association of Pharmaceutical Scientists: Development of Pediatric Formulations: Challenges and Opportunities. 
    Rockville, MD - 2/24/2014

Press Mentions

  • Moderna Shares TeenCOVE Study Results: Initial Data Reveals mRNA-Based Vaccine Safe & Effective for Adolescents 12 Yrs. & Up
    Moderna Shares TeenCOVE Study Results: Initial Data Reveals mRNA-Based Vaccine Safe & Effective for Adolescents 12 Yrs. & UpMay 26th, 2021
  • Critical Need for Pharmacologic Treatment Options in NAFLD: A Pediatric Perspective
    Critical Need for Pharmacologic Treatment Options in NAFLD: A Pediatric PerspectiveJanuary 21st, 2021
  • Advancing Clinical and Translational Science
    Advancing Clinical and Translational ScienceFebruary 16th, 2017

Hospital Affiliations